Clinical trial
A Multicenter Dosimetry Trial to Evaluate Radiation Absorbed Dose From Holmium-166-DOTMP in Patients With Multiple Myeloma
NCT00045136 is registered in ClinicalTrials.gov with Poniard Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Dosimetry Trial to Evaluate Radiation Absorbed Dose From Holmium-166-DOTMP in Patients With Multiple Myeloma
- Lead sponsor
- Poniard Pharmaceuticals
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2002
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
multiple myeloma and plasma cell neoplasm